Proof-of-Concept of miRNAs as efficient tumoral biomarkers
Project data and summary
In this proof-of-concept project we will develop a strategy for the accurate detection of miRNAs from liquid biopsies as tumoral biomarkers. The methodology will combine ultrasensitive luminiscence-based tools with the technology of the company DestiNA Genomics, a patent-protected, error-free technology for the detection of nucleic acids with single nucleotide accuracy. The outcomes of the project will be evaluated by the University of Granada Technology Transfer Office (OTRI-UGR) for rapid translation to the productive sector.
- Funding Body: Consejería de Economía, Conocimiento, Empresas y Universidad (Junta de Andalucía) and the European Regional Development Fund (ERDF).
- Code: AT17-5105_OTRI UGR
- PI: Prof. Angel Orte
- Departamento de Fisicoquímica. Facultad de Farmacia. Universidad de Granada (Spain)
- Funding: 45,818.39 €
- Other participants: Dr. E. Garcia-Fernandez, Dr. J. A. Gonzalez-Vera, Dr. S. Pernagallo, Dr. J. J. Diaz-Mochon
- Collaborating institutions: DestiNA Genómica S.L. (Granada, Spain)
Outcomes of the project
Conferences
- V Biennial Meeting of the Chemical Biology Group of the Real Sociedad Española de Química. Granada, February, 2020. 1 oral communication and 1 poster presentation.
- Invited seminar at the University of Jaen, Spain (September, 2020).
The project AT17-5105_OTRI UGR is funded by the Consejería de Economía, Conocimiento, Empresas y Universidad (Junta de Andalucía) and the European Regional Development Fund (ERDF).
